Voyager Therapeutics (VYGR) Misses Q4 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Voyager Therapeutics (VYGR) Misses Q4 EPS by 12c

Voyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update

March 17, 2016 7:00 AM EDT

Top-line Clinical Proof-of-Concept Data for VY-AADC01 for Advanced Parkinsons Disease On Track for Release in the Fourth Quarter of 2016

Strong Cash Position Projected to Support Operations into 2019

CAMBRIDGE, Mass., March 17, 2016 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today reported its 2015 fourth quarter and full year financial results, and also provided corporate highlights and upcoming milestones.

2015 was certainly a year of execution on all fronts and... More